COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Balance Sheet
NASDAQ:CLGN - Nasdaq - IL0004960188 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 0.00 | 30.15M | |||
| Cash Equivalents | 10.73M | 11.91M | 26.67M | 29.65M | 13.15M | |||
| Receivables | 440.00K | 583.00K | 393.00K | 550.00K | 690.00K | |||
| Inventories | 673.00K | 440.00K | 714.00K | 1.43M | 1.08M | |||
| Other Current Assets | 245.00K | 248.00K | 241.00K | 20.00K | 10.00K | |||
| Total Current Assets | 12.09M | 13.18M | 28.02M | 31.66M | 45.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.88M | 5.28M | 5.86M | 5.68M | 5.68M | |||
| Intangibles | 116.00K | 131.00K | 188.00K | 250.00K | 240.00K | |||
| Other Non-Current Assets | 117.00K | 118.00K | 57.00K | 190.00K | 210.00K | |||
| Total Non-Current Assets | 5.12M | 5.53M | 6.10M | 6.11M | 6.13M | |||
| TOTAL ASSETS | 17.21M | 18.71M | 34.13M | 37.77M | 51.22M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 732.00K | 2.10M | 2.27M | 1.97M | 1.95M | |||
| Accounts Payable | 1.97M | 870.00K | 980.00K | 1.13M | 1.03M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Total Current Liabilities | 2.70M | 2.97M | 3.25M | 3.11M | 3.01M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.11M | 2.27M | 2.54M | 2.38M | 3.09M | |||
| Total Non-Current Liabilities | 2.11M | 2.27M | 2.54M | 2.38M | 3.09M | |||
| TOTAL LIABILITIES | 4.81M | 5.25M | 5.79M | 5.49M | 6.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -114.80M | -113.35M | -96.74M | -89.72M | -72.80M | |||
| Additional Paid In Capital | 123.19M | 122.80M | 121.07M | 118.10M | 114.22M | |||
| Common Shares | 4.98M | 4.98M | 4.98M | 4.87M | 4.66M | |||
| Other Shareholders' Equity | -969.00K | -969.00K | -969.00K | -970.00K | -970.00K | |||
| Shares Outstanding | 11.45M | 11.45M | 11.45M | 11.19M | 10.77M | |||
| Tangible Book Value per Share | 1.07 | 1.16 | 2.46 | 2.86 | 4.17 | |||
| Total Shareholders' Equity | 12.40M | 13.46M | 28.34M | 32.28M | 45.12M | |||
| TOTAL LIABILITIES AND EQUITY | 17.21M | 18.71M | 34.13M | 37.77M | 51.22M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.48 | 4.44 | 8.62 | 10.18 | 14.98 | |||
| Return On Assets (ROA) | -80.58% | -88.77% | -20.57% | -44.82% | 0.47% | |||
| Return On Equity (ROE) | -111.85% | -123.35% | -24.77% | -52.45% | 0.53% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 0.72% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 0.99% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 1.00% | |||
All data in USD , ROIC based on taxRate of 0.21